BCAB BioAtla Inc

$BCAB Remember the good ole days when BioGrifters of failed biotech companies would just use the go-to multilevel scam of switching to crypto (when it was hot) to try to salvage their faux biotech company that was 90-99% off its historic highs? Now, I guess the buzz word du jour - i mean, du an, is "A.I." so I should probably update my fictitious (but hopefully for not much longer) book: The BioGrifter's Wealth Transfer Playbook to reflect the "there's a new scam in town". Let's use A.I. to do some pretend math to convince more saps that our drug that either does not work or is not competitive actually could work.

$BCAB Exuma has agreeed to pay Bioatla $250,000 to satisfy their future royalty obligations. Doesn't appear to encompass any late stage assets. They did the same with Context as we all know. Bioatla is cleaning up its legacy licensing arrangements. Himalaya's CFO is moving over to Inversagen AI. So I would imagine we will hear something shortly regarding the Himalaya/Bioatla partnership being ammended or terminated. I think it's the last piece to clean up. Still trying to figure out exactly what is happening here. It's intriguing.

$BCAB I have no idea if Inversagen AI is funded or not. Seems odd to me that its Chairman, Jay Short, would go live with a website that makes certain representations about BCAB assets while he remains CEO of BCAB, but it DOES look like the AI-Biotech space is heating up. From today's WSJ: AI Biotech Enveda Doubles in Value to $2 Billion Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage trials....

$BCAB what a fraud.. only idiots keep there shares. And totally idiots buy. There are no value here. The one telling you that. Is the one who wan't to sell. Marked cap lower then a value of apartment tell you all you need to know

$BCAB looks to have an oral presentation at PEGS Europe on Nov 17 on its EpCAM program? Been a year since last update and many patients were still on treatment or just started. It's what got market excited for a second

$BCAB if they do a deal by EOY, as the filing/new website suggests, probably 5-10x upside from here depending on how much they get for Oz-V. $2M market cap and last year were supposed to get $40M upfront for 35% of the drug, so over $100M valuation for Oz-V alone

$BCAB what are the latest proposed exec bonuses for driving this into the ground? Bonuses for bankruptcy, hilarious incentive plan.

$BCAB One thing I find particularly interesting on the Inversagen AI website is this comment. "Lloyd's of London has agreed to insure clinical trials on the strength of the same risk analysis." I have actually never seen this in any of the clinical stage biotechs I have followed. So I guess that whoever funds this trial has very little risk. Am I seeing this right? Lloyd's actually pays back the financer if the clinical trial fails? Weird. Cool, but weird.🤔

$BCAB key words "In view of the ongoing strategic process...the Board approved a partial reinstatement of the retention bonus program"

$BCAB It seems they did not put much effort into defending their delisting even up until the very last moment.

$BCAB Thank you for your email and your questions. I will pass them along and hopefully be able to get back to you this week with responses. In the interim, I have requested that the proxy solicitor reach out to you directly to provide voting assistance. You should receive an email communication from Stephen Freyman (sfreyman@allianceadvisors.com) shortly who can provide voting assistance. I sincerely appreciate your patience and support. Best, Sheri

$BCAB Hello, We would like to arrange a call with Rick Waldron, our CFO, and Chris Vasquez, our VP Finance to discuss your questions. Is there a time day / time that works best for you? Thank you, Sheri

$BCAB entered a $40 million standby equity purchase agreement with Yorkville, paying a $500K commitment fee.

$BCAB do it hurt in your behind..? Jay is pushing it up slowly on you guys. You will lose all. And Jay will keep on smiling and pull it out of you..

$BCAB now that sievers left it’s down to Jay and a junior accountant with a CFO title. Next up is a sale of desks and computer equipment in front of of their office…